Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Regen BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Regen BioPharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Regen BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Regen BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Regen BioPharma Inc, Medical Devices Deals, 2012 to YTD 2018 10
Regen BioPharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Regen BioPharma Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Regen BioPharma Acquires Labs Facilities in US 13
Regen BioPharma Acquires Issued Patent and Preclinical Data Package for Targeting Cancer Stem Cell 14
Regen BioPharma to Acquire Cancer Stem Cell Intellectual Property from University of Toronto 15
Regen BioPharma Completes Acquisition Of Patented Intellectual Property Of Cancer Gene-Silencing Technology 16
Venture Financing 17
Regen BioPharma Raises US$20 Million In Venture Financing 17
Partnerships 18
Regen BioPharma Enters into Agreement with ChemDiv 18
Regen BioPharma to Enter into Agreement with Eli Lilly 19
Regen BioPharma Enters into Research Agreement with National Institutes of Health 20
Licensing Agreements 21
CheckPoint Immunology Enters into Licensing Agreement with Regen BioPharma 21
Benitec Biopharma Enters Into Licensing Agreement With Regen BioPharma For ddRNAi Gene Silencing Technology 22
Regen BioPharma Enters Licensing Agreement with Pan Am Cancer Treatment Center 24
Equity Offering 25
Regen BioPharma Raises USD0.05 Million in Private Placement of Units 25
Regen BioPharma Raises USD0.05 Million in Private Placement of Units 26
Regen BioPharma Raises Funding in Private Placement of Common Stock 27
Regen BioPharma Raises Funds in Private Placement of Shares 28
Regen BioPharma Raises Funds in Private Placement of Units 29
Regen BioPharma Raises Funding in Private Placement of Series A Preferred Stock 30
Regen BioPharma Raises USD0.15 Million in Private Placement of Units 31
Regen BioPharma Raises USD0.1 Million in Private Placement of Series A Preferred Stock 32
Regen BioPharma Raises funds in Private Placement 33
Regen BioPharma Raises USD0.1 Million in Private Placement of Shares 34
Regen BioPharma Raises Funds in Private Placement of Series A Preferred Stock 35
Regen BioPharma Raises USD0.1 Million in Private Placement of Shares 36
Regen BioPharma Raises USD0.1 Million in Private Placement of Shares 37
Regen BioPharma Raises USD0.1 Million in Private Placement of Shares 38
Regen BioPharma Raises USD0.1 Million in Private Placement of Shares 39
Debt Offering 40
Regen BioPharma Raises Funds in Public Offering of 10% Notes Due 2020 40
Regen BioPharma Raises Funds in Public Offering of 10% Notes Due 2020 41
Regen BioPharma Raises Funds in Public Offering of 10% Notes Due 2020 42
Regen BioPharma Raises Funds in Public Offering of 10% Notes Due 2020 43
Regen BioPharma Inc – Key Competitors 44
Regen BioPharma Inc – Key Employees 45
Regen BioPharma Inc – Locations And Subsidiaries 46
Head Office 46
Other Locations & Subsidiaries 46
Recent Developments 47
Corporate Communications 47
Oct 30, 2017: Regen BioPharma Announces Former Eli Lilly Executive and Current CVS Board Member will Lead Newly Formed Business Advisory Board (BAB) 47
Product News 48
11/08/2017: Regen BioPharma’s Chief Scientific Officer Explains the Link Between its NR2F6 Medicinal Chemistry and Three-Dimensional X-Ray Structure Programs 48
Oct 23, 2017: Regen BioPharma Begins Program to Determine the 3-Dimensional Crystal Structure of NR2F6 49
10/16/2017: Regen BioPharma Researchers Capitalize on Key Structure in Compounds that Activate Checkpoint NR2F6 for the Potential Treatment of Autoimmune Diseases 50
10/03/2017: Regen BioPharma Researchers Demonstrate Direct Binding of Proprietary Agonists to Immune Checkpoint NR2F6 51
09/06/2017: Regen BioPharma Researchers Identify Key Structure in Compounds that Activate NR2F6 52
07/25/2017: Regen BioPharma Research Demonstrates Ex-Vivo Immune Suppression With Novel NR2F6 Activators 53
Jul 12, 2017: Regen BioPharma Researchers Discover New Dynamic Compound Which Modulates the NR2F6 Checkpoint 54
May 16, 2017: Regen BioPharma Sees Additional Positive Results on its Medicinal Chemistry Optimization for Modulating NR2F6 Checkpoint for Treating Cancer and Autoimmune Diseases 55
Apr 18, 2017: Regen BioPharma Identifies Three New Series of Compounds That Activate NR2F6 56
Apr 12, 2017: Regen BioPharma Sees Success in Its Pre-Clinical Small Molecule Optimization Program for NR2F6 57
Mar 23, 2017: Regen BioPharma Provides Update on NR2F6 Small Molecule Optimization Program for Treating Cancer and Arthritis 58
Appendix 59
Methodology 59
About GlobalData 59
Contact Us 59
Disclaimer 59
Regen BioPharma Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Regen BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Regen BioPharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Regen BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Regen BioPharma Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Regen BioPharma Inc, Medical Devices Deals, 2012 to YTD 2018 10
Regen BioPharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Regen BioPharma Acquires Labs Facilities in US 13
Regen BioPharma Acquires Issued Patent and Preclinical Data Package for Targeting Cancer Stem Cell 14
Regen BioPharma to Acquire Cancer Stem Cell Intellectual Property from University of Toronto 15
Regen BioPharma Completes Acquisition Of Patented Intellectual Property Of Cancer Gene-Silencing Technology 16
Regen BioPharma Raises US$20 Million In Venture Financing 17
Regen BioPharma Enters into Agreement with ChemDiv 18
Regen BioPharma to Enter into Agreement with Eli Lilly 19
Regen BioPharma Enters into Research Agreement with National Institutes of Health 20
CheckPoint Immunology Enters into Licensing Agreement with Regen BioPharma 21
Benitec Biopharma Enters Into Licensing Agreement With Regen BioPharma For ddRNAi Gene Silencing Technology 22
Regen BioPharma Enters Licensing Agreement with Pan Am Cancer Treatment Center 24
Regen BioPharma Raises USD0.05 Million in Private Placement of Units 25
Regen BioPharma Raises USD0.05 Million in Private Placement of Units 26
Regen BioPharma Raises Funding in Private Placement of Common Stock 27
Regen BioPharma Raises Funds in Private Placement of Shares 28
Regen BioPharma Raises Funds in Private Placement of Units 29
Regen BioPharma Raises Funding in Private Placement of Series A Preferred Stock 30
Regen BioPharma Raises USD0.15 Million in Private Placement of Units 31
Regen BioPharma Raises USD0.1 Million in Private Placement of Series A Preferred Stock 32
Regen BioPharma Raises funds in Private Placement 33
Regen BioPharma Raises USD0.1 Million in Private Placement of Shares 34
Regen BioPharma Raises Funds in Private Placement of Series A Preferred Stock 35
Regen BioPharma Raises USD0.1 Million in Private Placement of Shares 36
Regen BioPharma Raises USD0.1 Million in Private Placement of Shares 37
Regen BioPharma Raises USD0.1 Million in Private Placement of Shares 38
Regen BioPharma Raises USD0.1 Million in Private Placement of Shares 39
Regen BioPharma Raises Funds in Public Offering of 10% Notes Due 2020 40
Regen BioPharma Raises Funds in Public Offering of 10% Notes Due 2020 41
Regen BioPharma Raises Funds in Public Offering of 10% Notes Due 2020 42
Regen BioPharma Raises Funds in Public Offering of 10% Notes Due 2020 43
Regen BioPharma Inc, Key Competitors 44
Regen BioPharma Inc, Key Employees 45
Regen BioPharma Inc, Subsidiaries 46
List of Figures
Regen BioPharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Regen BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Regen BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Regen BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Regen BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Regen BioPharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Regen BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Regen BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Regen BioPharma Inc, Medical Devices Deals, 2012 to YTD 2018 10